openPR Logo
Press release

Contrast Media/Contrast Agent Market- Global Industry Insights 2017 - 2025

02-28-2018 02:46 PM CET | Health & Medicine

Press release from: Medical Imaging

Contrast Media/Contrast Agent Market- Global Industry

Contrast media or contrast agent is used in medical imaging to enhance the image of body parts generated through X-rays, magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound. These substances are momentarily used to change the way imaging tools or x-rays interact with the body. Contrast media or contrast agent help the physicians to diagnose the medical conditions by improving the visibility of blood vessels or tissues and specific organs. These substances are added into the body prior to an imaging scan to help distinguish certain structures or tissues of interest from the surrounding tissue. Contrast media or contrast agent can be administered into the body in one of the four ways which include by enema (given rectally), orally, urethral, and by injecting into a blood vessel.

Rise in the gas micro bubble technology in MRI imaging is expected to boost the growth of contrast media/contrast agent market

The major factors driving the growth of contrast Media/contrast agent are the use of advanced technology such as gas micro bubble technology in MRI imaging, rising incidence of chronic diseases such as cardiac diseases, gastrointestinal disorders, and cancer. Advancements in medical imaging technology and increasing demand for image guided procedures and diagnostics is fueling the growth of the market. According to the International Agency for Research on Cancer (IARC), in 2012, an estimated 14.1 million new cancer cases and 8.2 million cancer deaths were recorded worldwide and by 2030 the number is expected to escalate to 21.7 million for new cancer cases and 13 million cancer deaths. However, side effects of contrast agents such as kidney diseases and high cost associated with the contrast media injectors are some of the factors that are hindering the growth of contrast media/ contrast agent market.

The approval and launch of innovative agents with safety profile is expected to fuel the growth of contrast media market. For instance, in 2016, FDA approved Gadavist (gadobutrol) injection manufactured by Bayer AG for use with magnetic resonance angiography (MRA) to evaluate renal artery disease use in adult and pediatric patients. Also, in May 2017, the FDA expanded indication for GE Healthcare’s Visipaque (iodixanol) for use in coronary computed tomography angiography (CCTA) for diagnostic evaluation of adult and pediatric patients 12 years of age or older with suspected coronary artery disease.

Request For Sample Copy@
https://www.coherentmarketinsights.com/insight/request-sample/1210

Contrast Media/ Contrast Agent Market Taxonomy

Contrast Media/ Contrast Agent Market is segmented on the basis of media type, route of administration, indication, end user and geography.

On the basis of media type, contrast media/contrast agent market is segmented into:
Microbubble Contrast Media
Iodinated Contrast Media
Barium-Based Contrast Media
Gadolinium-Based Contrast Media

On the basis of route of administration, contrast media/contrast agent market is segmented into:
Oral
Rectal
Intravenous
Urethral

On the basis of indication, contrast media/contrast agent market is segmented into:
Neurological Disorders
Nephrological Disorders
Cardiovascular Disorders
Gastrointestinal Disorders
Oncology
Musculoskeletal Disorders

On the basis of end user, contrast media/contrast agent market is segmented into:
Hospitals
Ambulatory Surgical Centers
Diagnostic Clinics

Increasing incidence of cancer and cardiac disorders is expected to dominate North America region in contrast media/contrast agent market

On the basis of region, the global contrast media/contrast agent market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America dominates the contrast media/ contrast agent in the global market, followed by Europe. Improved MRI techniques in cardiovascular diseases, rise in the number of cancer and cardiac disorders, advancements in diagnostic technology, image guided surgical procedures are the factors that has propelled the growth of contrast media/contrast agent market in the North America region. According to the National Cancer Institute, in 2016, an estimated 1,685,210 new cases of cancer were diagnosed in the U.S. Also, according to the Centers for Disease Control and Prevention (CDC), 2017, an estimated 28.4 million heart cases were diagnosed in the U.S.

Key players operating in the market

In March, 2017, GE Healthcare has launched Clariscan, a gadolinium based contrast agent designed to support effective visualization of abnormalities in the spine, brain and associated tissues. Clariscan, also known to be a gold standard detection tool in MR imaging, allows prompt detection of abnormalities by helping in improving contrast between pathological and normal tissue.

The key players operating in the contrast media/contrast agent market include Lantheus Medical Imaging, GE Healthcare, Bayer HealthCare, Bracco Imaging S.p.A, NanoPET Pharma GmbH, Guerbet Group, CMC Contrast AB, Daiichi Sankyo, and Subhra Pharma Private Limited.

Get More Details On this Report:
https://www.coherentmarketinsights.com/ongoing-insight/contrast-media-contrast-agent-market-1210

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Contrast Media/Contrast Agent Market- Global Industry Insights 2017 - 2025 here

News-ID: 961412 • Views: 365

More Releases from Medical Imaging

Global Medical Imaging Market Report 2019 Companies included Toshiba Medical Sys …
Market Reports Company has recently published 7th edition of Medical Imaging Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026. For inquiry or free sample pages email us at: sales@marketreportscompany.com The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Medical Imaging market was valued at USD xx
Near Infrared Medical Imaging Market by Application (in-vivo Imaging, Cancer Sur …
On the basis of region, the global near infrared medical imaging market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global near infrared medical imaging market and is expected to retain its dominance over the forecast period, owing to large population suffering from breast cancer and other neurological diseases. Click To Continue Reading: https://www.coherentmarketinsights.com/ongoing-insight/near-infrared-medical-imaging-market-1682 According to the American
Contrast Media/Contrast Agent Market Global Trends And Growth
Contrast media or contrast agent is used in medical imaging to enhance the image of body parts generated through X-rays, magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound. These substances are momentarily used to change the way imaging tools or x-rays interact with the body. Contrast media or contrast agent help the physicians to diagnose the medical conditions by improving the visibility of blood vessels or tissues and specific
Positron Emission Tomography Market Global Industry Insights, Trends Analysis an …
Positron emission tomography (PET) is an imaging technique that is used to examine the diseases and metabolic activities of the tissues and organs inside the body with the use of radiotracer that is administered intravenously.. In this technique the scan uses a special dye that has a radioactive tracers, this tracer is administered as an intravenous injection labelled with oxygen15, nitrogen13 and fluorine18 (C-11, Fl-18, O-15 or N-13). These tracers

All 5 Releases


More Releases for Contrast

Global Contrast Media/Contrast Agents Market Research Report
This report studies the global Contrast Media/Contrast Agents market status and forecast, categorizes the global Contrast Media/Contrast Agents market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Contrast Media/Contrast Agents market size was xx million US$ and it is expected to reach xx million
Contrast Media/Contrast Agent Market Global Trends And Growth
Contrast media or contrast agent is used in medical imaging to enhance the image of body parts generated through X-rays, magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound. These substances are momentarily used to change the way imaging tools or x-rays interact with the body. Contrast media or contrast agent help the physicians to diagnose the medical conditions by improving the visibility of blood vessels or tissues and specific
Contrast Induced Nephropathy - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Contrast Induced Nephropathy - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Contrast Induced Nephropathy - Pipeline Review, H2 2017, provides an overview of the Contrast Induced Nephropathy (Genito Urinary System And Sex Hormones) pipeline landscape. Contrast-induced nephropathy (CIN) is defined as the impairment of renal function
Global Contrast Injector Market Research Report 2017
n this report, the global Contrast Injector market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request Report Sample: https://goo.gl/tM1q4E Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Contrast Injector in these regions, from 2012 to
Contrast Media/Contrast Agent Market: An Overview of Growth Factors
Contrast medium or contrast agent is a substance used in medical imaging to enhance the contrast of fluids or structures inside the body. These help in better imaging of anatomical structures and organs by increasing the image contrast. Hence, these are helpful in diagnostic methods such as CT scan and in some critical surgeries. The global contrast media or contrast agent market is a fairly mature, and is expected to
Global Contrast Media (Contrast Agents) Market 2017 - Bayer Healthcare, Bracco I …
The market research report by QY Research provides detailed study on the overall Contrast Media (Contrast Agents) market size, its financial positions, its unique selling points, key products, and key developments. This research report has segmented the Contrast Media (Contrast Agents) market based on the segments covering all the domains in terms of type, country, region, forecasting revenues, and market share, along with analysis of latest trends in every sub-segment. CLICK